Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Labetalol hydrochloride 100 mg oral tablet |
Is a |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
|
Labetalol hydrochloride 200 mg oral tablet |
Is a |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
|
Labetalol hydrochloride 50 mg oral tablet |
Is a |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
|
chlorhydrate de labétalol 5 mg/mL, ampoule de 20 mL de solution pour injection |
Is a |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
|
Labetalol hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
|
Labetalol hydrochloride 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
|
Labetalol hydrochloride 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
|
Labetalol hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
|
chlorhydrate de labétalol 5 mg/mL, ampoule de 20 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
|
Labetalol hydrochloride 5mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
|
Labetalol hydrochloride 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
|
Labetalol hydrochloride 50mg/10mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
|
Hydrochlorothiazide + labetalol hydrochloride 25mg/200mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
|
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
|
Labetalol hydrochloride 5mg/ml injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
|
Labetalol hydrochloride 5mg/ml injection solution 40mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
|
Labetalol hydrochloride 5mg/ml injection solution 4mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
|
Labetalol hydrochloride 50mg/10mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
|
Labetalol hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Labetalol hydrochloride 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Labetalol hydrochloride 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Labetalol hydrochloride 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Labetalol hydrochloride 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Labetalol hydrochloride 400 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Labetalol hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Labetalol hydrochloride 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Labetalol hydrochloride 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Labetalol hydrochloride 300 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Labetalol hydrochloride 100 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Labetalol hydrochloride 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Labetalol hydrochloride 400 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Labetalol hydrochloride 300 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Labetalol hydrochloride 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely labetalol hydrochloride 100 milligram/20 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely labetalol hydrochloride 100 milligram/20 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Labetalol hydrochloride 5 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Labetalol hydrochloride 5 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Labetalol hydrochloride |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Labetalol hydrochloride |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Labetalol hydrochloride |
Inferred relationship |
Some |
2 |